Global Immunocell Therapy Market Research Report 2026(Status and Outlook)
Immune therapy is a new class of cancer treatment designed to boost or enhance the body?s immune system to more efficiently target and destroy cancerous cells. Many experts believe that immunotherapy represents the most promising new cancer treatment since the development of chemotherapy.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Immunocell Therapy market size was estimated at USD 2368.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 13.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Immunocell Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Immunocell Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Immunocell Therapy market.
Global Immunocell Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
Autolus Therapeutics(Pipeline)
Sorrento Therapeutics(Pipeline)
Mustang Bio(Pipeline)
Bluebird Bio(Pipeline)
Cellectis(Pipeline)
Allogene Therapeutics(Pipeline)
Celyad(Pipeline)
Market Segmentation (by Type)
Chimeric Antigen Receptor (CAR) T Cell Therapy
Natural Killer (NK) Cell Therapy
Others
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Immunocell Therapy Market
Overview of the regional outlook of the Immunocell Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immunocell Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Immunocell Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Immunocell Therapy market size was estimated at USD 2368.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 13.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Immunocell Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Immunocell Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Immunocell Therapy market.
Global Immunocell Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
Autolus Therapeutics(Pipeline)
Sorrento Therapeutics(Pipeline)
Mustang Bio(Pipeline)
Bluebird Bio(Pipeline)
Cellectis(Pipeline)
Allogene Therapeutics(Pipeline)
Celyad(Pipeline)
Market Segmentation (by Type)
Chimeric Antigen Receptor (CAR) T Cell Therapy
Natural Killer (NK) Cell Therapy
Others
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Immunocell Therapy Market
Overview of the regional outlook of the Immunocell Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immunocell Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Immunocell Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Immunocell Therapy
1.2 Key Market Segments
1.2.1 Immunocell Therapy Segment by Type
1.2.2 Immunocell Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 IMMUNOCELL THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Immunocell Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Immunocell Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 IMMUNOCELL THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Immunocell Therapy Product Life Cycle
3.3 Global Immunocell Therapy Sales by Manufacturers (2020-2025)
3.4 Global Immunocell Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Immunocell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Immunocell Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Immunocell Therapy Market Competitive Situation and Trends
3.8.1 Immunocell Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Immunocell Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 IMMUNOCELL THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Immunocell Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF IMMUNOCELL THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Immunocell Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Immunocell Therapy Market
5.7 ESG Ratings of Leading Companies
6 IMMUNOCELL THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immunocell Therapy Sales Market Share by Type (2020-2025)
6.3 Global Immunocell Therapy Market Size by Type (2020-2025)
6.4 Global Immunocell Therapy Price by Type (2020-2025)
7 IMMUNOCELL THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immunocell Therapy Market Sales by Application (2020-2025)
7.3 Global Immunocell Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Immunocell Therapy Sales Growth Rate by Application (2020-2025)
8 IMMUNOCELL THERAPY MARKET SALES BY REGION
8.1 Global Immunocell Therapy Sales by Region
8.1.1 Global Immunocell Therapy Sales by Region
8.1.2 Global Immunocell Therapy Sales Market Share by Region
8.2 Global Immunocell Therapy Market Size by Region
8.2.1 Global Immunocell Therapy Market Size by Region
8.2.2 Global Immunocell Therapy Market Size by Region
8.3 North America
8.3.1 North America Immunocell Therapy Sales by Country
8.3.2 North America Immunocell Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Immunocell Therapy Sales by Country
8.4.2 Europe Immunocell Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Immunocell Therapy Sales by Region
8.5.2 Asia Pacific Immunocell Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Immunocell Therapy Sales by Country
8.6.2 South America Immunocell Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Immunocell Therapy Sales by Region
8.7.2 Middle East and Africa Immunocell Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 IMMUNOCELL THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Immunocell Therapy by Region(2020-2025)
9.2 Global Immunocell Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Immunocell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Immunocell Therapy Production
9.4.1 North America Immunocell Therapy Production Growth Rate (2020-2025)
9.4.2 North America Immunocell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Immunocell Therapy Production
9.5.1 Europe Immunocell Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Immunocell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Immunocell Therapy Production (2020-2025)
9.6.1 Japan Immunocell Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Immunocell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Immunocell Therapy Production (2020-2025)
9.7.1 China Immunocell Therapy Production Growth Rate (2020-2025)
9.7.2 China Immunocell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis
10.1.1 Novartis Basic Information
10.1.2 Novartis Immunocell Therapy Product Overview
10.1.3 Novartis Immunocell Therapy Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Gilead Sciences
10.2.1 Gilead Sciences Basic Information
10.2.2 Gilead Sciences Immunocell Therapy Product Overview
10.2.3 Gilead Sciences Immunocell Therapy Product Market Performance
10.2.4 Gilead Sciences Business Overview
10.2.5 Gilead Sciences SWOT Analysis
10.2.6 Gilead Sciences Recent Developments
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Basic Information
10.3.2 Bristol-Myers Squibb Immunocell Therapy Product Overview
10.3.3 Bristol-Myers Squibb Immunocell Therapy Product Market Performance
10.3.4 Bristol-Myers Squibb Business Overview
10.3.5 Bristol-Myers Squibb SWOT Analysis
10.3.6 Bristol-Myers Squibb Recent Developments
10.4 J and J
10.4.1 J and J Basic Information
10.4.2 J and J Immunocell Therapy Product Overview
10.4.3 J and J Immunocell Therapy Product Market Performance
10.4.4 J and J Business Overview
10.4.5 J and J Recent Developments
10.5 JW Therapeutics
10.5.1 JW Therapeutics Basic Information
10.5.2 JW Therapeutics Immunocell Therapy Product Overview
10.5.3 JW Therapeutics Immunocell Therapy Product Market Performance
10.5.4 JW Therapeutics Business Overview
10.5.5 JW Therapeutics Recent Developments
10.6 FOSUNKite
10.6.1 FOSUNKite Basic Information
10.6.2 FOSUNKite Immunocell Therapy Product Overview
10.6.3 FOSUNKite Immunocell Therapy Product Market Performance
10.6.4 FOSUNKite Business Overview
10.6.5 FOSUNKite Recent Developments
10.7 CARsgen Therapeutics (Pipeline)
10.7.1 CARsgen Therapeutics (Pipeline) Basic Information
10.7.2 CARsgen Therapeutics (Pipeline) Immunocell Therapy Product Overview
10.7.3 CARsgen Therapeutics (Pipeline) Immunocell Therapy Product Market Performance
10.7.4 CARsgen Therapeutics (Pipeline) Business Overview
10.7.5 CARsgen Therapeutics (Pipeline) Recent Developments
10.8 Autolus Therapeutics(Pipeline)
10.8.1 Autolus Therapeutics(Pipeline) Basic Information
10.8.2 Autolus Therapeutics(Pipeline) Immunocell Therapy Product Overview
10.8.3 Autolus Therapeutics(Pipeline) Immunocell Therapy Product Market Performance
10.8.4 Autolus Therapeutics(Pipeline) Business Overview
10.8.5 Autolus Therapeutics(Pipeline) Recent Developments
10.9 Sorrento Therapeutics(Pipeline)
10.9.1 Sorrento Therapeutics(Pipeline) Basic Information
10.9.2 Sorrento Therapeutics(Pipeline) Immunocell Therapy Product Overview
10.9.3 Sorrento Therapeutics(Pipeline) Immunocell Therapy Product Market Performance
10.9.4 Sorrento Therapeutics(Pipeline) Business Overview
10.9.5 Sorrento Therapeutics(Pipeline) Recent Developments
10.10 Mustang Bio(Pipeline)
10.10.1 Mustang Bio(Pipeline) Basic Information
10.10.2 Mustang Bio(Pipeline) Immunocell Therapy Product Overview
10.10.3 Mustang Bio(Pipeline) Immunocell Therapy Product Market Performance
10.10.4 Mustang Bio(Pipeline) Business Overview
10.10.5 Mustang Bio(Pipeline) Recent Developments
10.11 Bluebird Bio(Pipeline)
10.11.1 Bluebird Bio(Pipeline) Basic Information
10.11.2 Bluebird Bio(Pipeline) Immunocell Therapy Product Overview
10.11.3 Bluebird Bio(Pipeline) Immunocell Therapy Product Market Performance
10.11.4 Bluebird Bio(Pipeline) Business Overview
10.11.5 Bluebird Bio(Pipeline) Recent Developments
10.12 Cellectis(Pipeline)
10.12.1 Cellectis(Pipeline) Basic Information
10.12.2 Cellectis(Pipeline) Immunocell Therapy Product Overview
10.12.3 Cellectis(Pipeline) Immunocell Therapy Product Market Performance
10.12.4 Cellectis(Pipeline) Business Overview
10.12.5 Cellectis(Pipeline) Recent Developments
10.13 Allogene Therapeutics(Pipeline)
10.13.1 Allogene Therapeutics(Pipeline) Basic Information
10.13.2 Allogene Therapeutics(Pipeline) Immunocell Therapy Product Overview
10.13.3 Allogene Therapeutics(Pipeline) Immunocell Therapy Product Market Performance
10.13.4 Allogene Therapeutics(Pipeline) Business Overview
10.13.5 Allogene Therapeutics(Pipeline) Recent Developments
10.14 Celyad(Pipeline)
10.14.1 Celyad(Pipeline) Basic Information
10.14.2 Celyad(Pipeline) Immunocell Therapy Product Overview
10.14.3 Celyad(Pipeline) Immunocell Therapy Product Market Performance
10.14.4 Celyad(Pipeline) Business Overview
10.14.5 Celyad(Pipeline) Recent Developments
11 IMMUNOCELL THERAPY MARKET FORECAST BY REGION
11.1 Global Immunocell Therapy Market Size Forecast
11.2 Global Immunocell Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Immunocell Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Immunocell Therapy Market Size Forecast by Region
11.2.4 South America Immunocell Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Immunocell Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Immunocell Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Immunocell Therapy by Type (2026-2035)
12.1.2 Global Immunocell Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Immunocell Therapy by Type (2026-2035)
12.2 Global Immunocell Therapy Market Forecast by Application (2026-2035)
12.2.1 Global Immunocell Therapy Sales (K Units) Forecast by Application
12.2.2 Global Immunocell Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Immunocell Therapy
1.2 Key Market Segments
1.2.1 Immunocell Therapy Segment by Type
1.2.2 Immunocell Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 IMMUNOCELL THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Immunocell Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Immunocell Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 IMMUNOCELL THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Immunocell Therapy Product Life Cycle
3.3 Global Immunocell Therapy Sales by Manufacturers (2020-2025)
3.4 Global Immunocell Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Immunocell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Immunocell Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Immunocell Therapy Market Competitive Situation and Trends
3.8.1 Immunocell Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Immunocell Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 IMMUNOCELL THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Immunocell Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF IMMUNOCELL THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Immunocell Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Immunocell Therapy Market
5.7 ESG Ratings of Leading Companies
6 IMMUNOCELL THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immunocell Therapy Sales Market Share by Type (2020-2025)
6.3 Global Immunocell Therapy Market Size by Type (2020-2025)
6.4 Global Immunocell Therapy Price by Type (2020-2025)
7 IMMUNOCELL THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immunocell Therapy Market Sales by Application (2020-2025)
7.3 Global Immunocell Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Immunocell Therapy Sales Growth Rate by Application (2020-2025)
8 IMMUNOCELL THERAPY MARKET SALES BY REGION
8.1 Global Immunocell Therapy Sales by Region
8.1.1 Global Immunocell Therapy Sales by Region
8.1.2 Global Immunocell Therapy Sales Market Share by Region
8.2 Global Immunocell Therapy Market Size by Region
8.2.1 Global Immunocell Therapy Market Size by Region
8.2.2 Global Immunocell Therapy Market Size by Region
8.3 North America
8.3.1 North America Immunocell Therapy Sales by Country
8.3.2 North America Immunocell Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Immunocell Therapy Sales by Country
8.4.2 Europe Immunocell Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Immunocell Therapy Sales by Region
8.5.2 Asia Pacific Immunocell Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Immunocell Therapy Sales by Country
8.6.2 South America Immunocell Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Immunocell Therapy Sales by Region
8.7.2 Middle East and Africa Immunocell Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 IMMUNOCELL THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Immunocell Therapy by Region(2020-2025)
9.2 Global Immunocell Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Immunocell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Immunocell Therapy Production
9.4.1 North America Immunocell Therapy Production Growth Rate (2020-2025)
9.4.2 North America Immunocell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Immunocell Therapy Production
9.5.1 Europe Immunocell Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Immunocell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Immunocell Therapy Production (2020-2025)
9.6.1 Japan Immunocell Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Immunocell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Immunocell Therapy Production (2020-2025)
9.7.1 China Immunocell Therapy Production Growth Rate (2020-2025)
9.7.2 China Immunocell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis
10.1.1 Novartis Basic Information
10.1.2 Novartis Immunocell Therapy Product Overview
10.1.3 Novartis Immunocell Therapy Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Gilead Sciences
10.2.1 Gilead Sciences Basic Information
10.2.2 Gilead Sciences Immunocell Therapy Product Overview
10.2.3 Gilead Sciences Immunocell Therapy Product Market Performance
10.2.4 Gilead Sciences Business Overview
10.2.5 Gilead Sciences SWOT Analysis
10.2.6 Gilead Sciences Recent Developments
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Basic Information
10.3.2 Bristol-Myers Squibb Immunocell Therapy Product Overview
10.3.3 Bristol-Myers Squibb Immunocell Therapy Product Market Performance
10.3.4 Bristol-Myers Squibb Business Overview
10.3.5 Bristol-Myers Squibb SWOT Analysis
10.3.6 Bristol-Myers Squibb Recent Developments
10.4 J and J
10.4.1 J and J Basic Information
10.4.2 J and J Immunocell Therapy Product Overview
10.4.3 J and J Immunocell Therapy Product Market Performance
10.4.4 J and J Business Overview
10.4.5 J and J Recent Developments
10.5 JW Therapeutics
10.5.1 JW Therapeutics Basic Information
10.5.2 JW Therapeutics Immunocell Therapy Product Overview
10.5.3 JW Therapeutics Immunocell Therapy Product Market Performance
10.5.4 JW Therapeutics Business Overview
10.5.5 JW Therapeutics Recent Developments
10.6 FOSUNKite
10.6.1 FOSUNKite Basic Information
10.6.2 FOSUNKite Immunocell Therapy Product Overview
10.6.3 FOSUNKite Immunocell Therapy Product Market Performance
10.6.4 FOSUNKite Business Overview
10.6.5 FOSUNKite Recent Developments
10.7 CARsgen Therapeutics (Pipeline)
10.7.1 CARsgen Therapeutics (Pipeline) Basic Information
10.7.2 CARsgen Therapeutics (Pipeline) Immunocell Therapy Product Overview
10.7.3 CARsgen Therapeutics (Pipeline) Immunocell Therapy Product Market Performance
10.7.4 CARsgen Therapeutics (Pipeline) Business Overview
10.7.5 CARsgen Therapeutics (Pipeline) Recent Developments
10.8 Autolus Therapeutics(Pipeline)
10.8.1 Autolus Therapeutics(Pipeline) Basic Information
10.8.2 Autolus Therapeutics(Pipeline) Immunocell Therapy Product Overview
10.8.3 Autolus Therapeutics(Pipeline) Immunocell Therapy Product Market Performance
10.8.4 Autolus Therapeutics(Pipeline) Business Overview
10.8.5 Autolus Therapeutics(Pipeline) Recent Developments
10.9 Sorrento Therapeutics(Pipeline)
10.9.1 Sorrento Therapeutics(Pipeline) Basic Information
10.9.2 Sorrento Therapeutics(Pipeline) Immunocell Therapy Product Overview
10.9.3 Sorrento Therapeutics(Pipeline) Immunocell Therapy Product Market Performance
10.9.4 Sorrento Therapeutics(Pipeline) Business Overview
10.9.5 Sorrento Therapeutics(Pipeline) Recent Developments
10.10 Mustang Bio(Pipeline)
10.10.1 Mustang Bio(Pipeline) Basic Information
10.10.2 Mustang Bio(Pipeline) Immunocell Therapy Product Overview
10.10.3 Mustang Bio(Pipeline) Immunocell Therapy Product Market Performance
10.10.4 Mustang Bio(Pipeline) Business Overview
10.10.5 Mustang Bio(Pipeline) Recent Developments
10.11 Bluebird Bio(Pipeline)
10.11.1 Bluebird Bio(Pipeline) Basic Information
10.11.2 Bluebird Bio(Pipeline) Immunocell Therapy Product Overview
10.11.3 Bluebird Bio(Pipeline) Immunocell Therapy Product Market Performance
10.11.4 Bluebird Bio(Pipeline) Business Overview
10.11.5 Bluebird Bio(Pipeline) Recent Developments
10.12 Cellectis(Pipeline)
10.12.1 Cellectis(Pipeline) Basic Information
10.12.2 Cellectis(Pipeline) Immunocell Therapy Product Overview
10.12.3 Cellectis(Pipeline) Immunocell Therapy Product Market Performance
10.12.4 Cellectis(Pipeline) Business Overview
10.12.5 Cellectis(Pipeline) Recent Developments
10.13 Allogene Therapeutics(Pipeline)
10.13.1 Allogene Therapeutics(Pipeline) Basic Information
10.13.2 Allogene Therapeutics(Pipeline) Immunocell Therapy Product Overview
10.13.3 Allogene Therapeutics(Pipeline) Immunocell Therapy Product Market Performance
10.13.4 Allogene Therapeutics(Pipeline) Business Overview
10.13.5 Allogene Therapeutics(Pipeline) Recent Developments
10.14 Celyad(Pipeline)
10.14.1 Celyad(Pipeline) Basic Information
10.14.2 Celyad(Pipeline) Immunocell Therapy Product Overview
10.14.3 Celyad(Pipeline) Immunocell Therapy Product Market Performance
10.14.4 Celyad(Pipeline) Business Overview
10.14.5 Celyad(Pipeline) Recent Developments
11 IMMUNOCELL THERAPY MARKET FORECAST BY REGION
11.1 Global Immunocell Therapy Market Size Forecast
11.2 Global Immunocell Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Immunocell Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Immunocell Therapy Market Size Forecast by Region
11.2.4 South America Immunocell Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Immunocell Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Immunocell Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Immunocell Therapy by Type (2026-2035)
12.1.2 Global Immunocell Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Immunocell Therapy by Type (2026-2035)
12.2 Global Immunocell Therapy Market Forecast by Application (2026-2035)
12.2.1 Global Immunocell Therapy Sales (K Units) Forecast by Application
12.2.2 Global Immunocell Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Immunocell Therapy Market Size by Type (M USD)
Table 4. Global Immunocell Therapy Market Size by Application
Table 5. Immunocell Therapy Market Size Comparison by Region (M USD)
Table 6. Global Immunocell Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Immunocell Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Immunocell Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Immunocell Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunocell Therapy as of 2025)
Table 11. Global Market Immunocell Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Immunocell Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Immunocell Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Immunocell Therapy Sales by Type (K Units)
Table 27. Global Immunocell Therapy Market Size by Type (M USD)
Table 28. Global Immunocell Therapy Sales (K Units) by Type (2020-2025)
Table 29. Global Immunocell Therapy Sales Market Share by Type (2020-2025)
Table 30. Global Immunocell Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global Immunocell Therapy Market Share by Type (2020-2025)
Table 32. Global Immunocell Therapy Price (USD/Unit) by Type (2020-2025)
Table 33. Global Immunocell Therapy Sales (K Units) by Application
Table 34. Global Immunocell Therapy Market Size by Application
Table 35. Global Immunocell Therapy Sales by Application (2020-2025) & (K Units)
Table 36. Global Immunocell Therapy Sales Market Share by Application (2020-2025)
Table 37. Global Immunocell Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Immunocell Therapy Market Share by Application (2020-2025)
Table 39. Global Immunocell Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global Immunocell Therapy Sales by Region (2020-2025) & (K Units)
Table 41. Global Immunocell Therapy Sales Market Share by Region (2020-2025)
Table 42. Global Immunocell Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Immunocell Therapy Market Size by Region (2020-2025)
Table 44. North America Immunocell Therapy Sales by Country (2020-2025) & (K Units)
Table 45. North America Immunocell Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Immunocell Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Europe Immunocell Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Immunocell Therapy Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Immunocell Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Immunocell Therapy Sales by Country (2020-2025) & (K Units)
Table 51. South America Immunocell Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Immunocell Therapy Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Immunocell Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Immunocell Therapy Production (K Units) by Region(2020-2025)
Table 55. Global Immunocell Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Immunocell Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global Immunocell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Immunocell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Immunocell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Immunocell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Immunocell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Novartis Basic Information
Table 63. Novartis Immunocell Therapy Product Overview
Table 64. Novartis Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Novartis Business Overview
Table 66. Novartis SWOT Analysis
Table 67. Novartis Recent Developments
Table 68. Gilead Sciences Basic Information
Table 69. Gilead Sciences Immunocell Therapy Product Overview
Table 70. Gilead Sciences Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Gilead Sciences Business Overview
Table 72. Gilead Sciences SWOT Analysis
Table 73. Gilead Sciences Recent Developments
Table 74. Bristol-Myers Squibb Basic Information
Table 75. Bristol-Myers Squibb Immunocell Therapy Product Overview
Table 76. Bristol-Myers Squibb Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Bristol-Myers Squibb Business Overview
Table 78. Bristol-Myers Squibb SWOT Analysis
Table 79. Bristol-Myers Squibb Recent Developments
Table 80. J and J Basic Information
Table 81. J and J Immunocell Therapy Product Overview
Table 82. J and J Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. J and J Business Overview
Table 84. J and J Recent Developments
Table 85. JW Therapeutics Basic Information
Table 86. JW Therapeutics Immunocell Therapy Product Overview
Table 87. JW Therapeutics Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. JW Therapeutics Business Overview
Table 89. JW Therapeutics Recent Developments
Table 90. FOSUNKite Basic Information
Table 91. FOSUNKite Immunocell Therapy Product Overview
Table 92. FOSUNKite Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. FOSUNKite Business Overview
Table 94. FOSUNKite Recent Developments
Table 95. CARsgen Therapeutics (Pipeline) Basic Information
Table 96. CARsgen Therapeutics (Pipeline) Immunocell Therapy Product Overview
Table 97. CARsgen Therapeutics (Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. CARsgen Therapeutics (Pipeline) Business Overview
Table 99. CARsgen Therapeutics (Pipeline) Recent Developments
Table 100. Autolus Therapeutics(Pipeline) Basic Information
Table 101. Autolus Therapeutics(Pipeline) Immunocell Therapy Product Overview
Table 102. Autolus Therapeutics(Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Autolus Therapeutics(Pipeline) Business Overview
Table 104. Autolus Therapeutics(Pipeline) Recent Developments
Table 105. Sorrento Therapeutics(Pipeline) Basic Information
Table 106. Sorrento Therapeutics(Pipeline) Immunocell Therapy Product Overview
Table 107. Sorrento Therapeutics(Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Sorrento Therapeutics(Pipeline) Business Overview
Table 109. Sorrento Therapeutics(Pipeline) Recent Developments
Table 110. Mustang Bio(Pipeline) Basic Information
Table 111. Mustang Bio(Pipeline) Immunocell Therapy Product Overview
Table 112. Mustang Bio(Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Mustang Bio(Pipeline) Business Overview
Table 114. Mustang Bio(Pipeline) Recent Developments
Table 115. Bluebird Bio(Pipeline) Basic Information
Table 116. Bluebird Bio(Pipeline) Immunocell Therapy Product Overview
Table 117. Bluebird Bio(Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Bluebird Bio(Pipeline) Business Overview
Table 119. Bluebird Bio(Pipeline) Recent Developments
Table 120. Cellectis(Pipeline) Basic Information
Table 121. Cellectis(Pipeline) Immunocell Therapy Product Overview
Table 122. Cellectis(Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Cellectis(Pipeline) Business Overview
Table 124. Cellectis(Pipeline) Recent Developments
Table 125. Allogene Therapeutics(Pipeline) Basic Information
Table 126. Allogene Therapeutics(Pipeline) Immunocell Therapy Product Overview
Table 127. Allogene Therapeutics(Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Allogene Therapeutics(Pipeline) Business Overview
Table 129. Allogene Therapeutics(Pipeline) Recent Developments
Table 130. Celyad(Pipeline) Basic Information
Table 131. Celyad(Pipeline) Immunocell Therapy Product Overview
Table 132. Celyad(Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Celyad(Pipeline) Business Overview
Table 134. Celyad(Pipeline) Recent Developments
Table 135. Global Immunocell Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 136. Global Immunocell Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Immunocell Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 138. North America Immunocell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Immunocell Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 140. Europe Immunocell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Immunocell Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 142. Asia Pacific Immunocell Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Immunocell Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 144. South America Immunocell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Immunocell Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Immunocell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Immunocell Therapy Sales Forecast by Type (2026-2035) & (K Units)
Table 148. Global Immunocell Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Immunocell Therapy Price Forecast by Type (2026-2035) & (USD/Unit)
Table 150. Global Immunocell Therapy Sales (K Units) Forecast by Application (2026-2035)
Table 151. Global Immunocell Therapy Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Immunocell Therapy Market Size by Type (M USD)
Table 4. Global Immunocell Therapy Market Size by Application
Table 5. Immunocell Therapy Market Size Comparison by Region (M USD)
Table 6. Global Immunocell Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Immunocell Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Immunocell Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Immunocell Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunocell Therapy as of 2025)
Table 11. Global Market Immunocell Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Immunocell Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Immunocell Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Immunocell Therapy Sales by Type (K Units)
Table 27. Global Immunocell Therapy Market Size by Type (M USD)
Table 28. Global Immunocell Therapy Sales (K Units) by Type (2020-2025)
Table 29. Global Immunocell Therapy Sales Market Share by Type (2020-2025)
Table 30. Global Immunocell Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global Immunocell Therapy Market Share by Type (2020-2025)
Table 32. Global Immunocell Therapy Price (USD/Unit) by Type (2020-2025)
Table 33. Global Immunocell Therapy Sales (K Units) by Application
Table 34. Global Immunocell Therapy Market Size by Application
Table 35. Global Immunocell Therapy Sales by Application (2020-2025) & (K Units)
Table 36. Global Immunocell Therapy Sales Market Share by Application (2020-2025)
Table 37. Global Immunocell Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Immunocell Therapy Market Share by Application (2020-2025)
Table 39. Global Immunocell Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global Immunocell Therapy Sales by Region (2020-2025) & (K Units)
Table 41. Global Immunocell Therapy Sales Market Share by Region (2020-2025)
Table 42. Global Immunocell Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Immunocell Therapy Market Size by Region (2020-2025)
Table 44. North America Immunocell Therapy Sales by Country (2020-2025) & (K Units)
Table 45. North America Immunocell Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Immunocell Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Europe Immunocell Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Immunocell Therapy Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Immunocell Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Immunocell Therapy Sales by Country (2020-2025) & (K Units)
Table 51. South America Immunocell Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Immunocell Therapy Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Immunocell Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Immunocell Therapy Production (K Units) by Region(2020-2025)
Table 55. Global Immunocell Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Immunocell Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global Immunocell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Immunocell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Immunocell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Immunocell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Immunocell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Novartis Basic Information
Table 63. Novartis Immunocell Therapy Product Overview
Table 64. Novartis Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Novartis Business Overview
Table 66. Novartis SWOT Analysis
Table 67. Novartis Recent Developments
Table 68. Gilead Sciences Basic Information
Table 69. Gilead Sciences Immunocell Therapy Product Overview
Table 70. Gilead Sciences Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Gilead Sciences Business Overview
Table 72. Gilead Sciences SWOT Analysis
Table 73. Gilead Sciences Recent Developments
Table 74. Bristol-Myers Squibb Basic Information
Table 75. Bristol-Myers Squibb Immunocell Therapy Product Overview
Table 76. Bristol-Myers Squibb Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Bristol-Myers Squibb Business Overview
Table 78. Bristol-Myers Squibb SWOT Analysis
Table 79. Bristol-Myers Squibb Recent Developments
Table 80. J and J Basic Information
Table 81. J and J Immunocell Therapy Product Overview
Table 82. J and J Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. J and J Business Overview
Table 84. J and J Recent Developments
Table 85. JW Therapeutics Basic Information
Table 86. JW Therapeutics Immunocell Therapy Product Overview
Table 87. JW Therapeutics Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. JW Therapeutics Business Overview
Table 89. JW Therapeutics Recent Developments
Table 90. FOSUNKite Basic Information
Table 91. FOSUNKite Immunocell Therapy Product Overview
Table 92. FOSUNKite Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. FOSUNKite Business Overview
Table 94. FOSUNKite Recent Developments
Table 95. CARsgen Therapeutics (Pipeline) Basic Information
Table 96. CARsgen Therapeutics (Pipeline) Immunocell Therapy Product Overview
Table 97. CARsgen Therapeutics (Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. CARsgen Therapeutics (Pipeline) Business Overview
Table 99. CARsgen Therapeutics (Pipeline) Recent Developments
Table 100. Autolus Therapeutics(Pipeline) Basic Information
Table 101. Autolus Therapeutics(Pipeline) Immunocell Therapy Product Overview
Table 102. Autolus Therapeutics(Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Autolus Therapeutics(Pipeline) Business Overview
Table 104. Autolus Therapeutics(Pipeline) Recent Developments
Table 105. Sorrento Therapeutics(Pipeline) Basic Information
Table 106. Sorrento Therapeutics(Pipeline) Immunocell Therapy Product Overview
Table 107. Sorrento Therapeutics(Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Sorrento Therapeutics(Pipeline) Business Overview
Table 109. Sorrento Therapeutics(Pipeline) Recent Developments
Table 110. Mustang Bio(Pipeline) Basic Information
Table 111. Mustang Bio(Pipeline) Immunocell Therapy Product Overview
Table 112. Mustang Bio(Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Mustang Bio(Pipeline) Business Overview
Table 114. Mustang Bio(Pipeline) Recent Developments
Table 115. Bluebird Bio(Pipeline) Basic Information
Table 116. Bluebird Bio(Pipeline) Immunocell Therapy Product Overview
Table 117. Bluebird Bio(Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Bluebird Bio(Pipeline) Business Overview
Table 119. Bluebird Bio(Pipeline) Recent Developments
Table 120. Cellectis(Pipeline) Basic Information
Table 121. Cellectis(Pipeline) Immunocell Therapy Product Overview
Table 122. Cellectis(Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Cellectis(Pipeline) Business Overview
Table 124. Cellectis(Pipeline) Recent Developments
Table 125. Allogene Therapeutics(Pipeline) Basic Information
Table 126. Allogene Therapeutics(Pipeline) Immunocell Therapy Product Overview
Table 127. Allogene Therapeutics(Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Allogene Therapeutics(Pipeline) Business Overview
Table 129. Allogene Therapeutics(Pipeline) Recent Developments
Table 130. Celyad(Pipeline) Basic Information
Table 131. Celyad(Pipeline) Immunocell Therapy Product Overview
Table 132. Celyad(Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Celyad(Pipeline) Business Overview
Table 134. Celyad(Pipeline) Recent Developments
Table 135. Global Immunocell Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 136. Global Immunocell Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Immunocell Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 138. North America Immunocell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Immunocell Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 140. Europe Immunocell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Immunocell Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 142. Asia Pacific Immunocell Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Immunocell Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 144. South America Immunocell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Immunocell Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Immunocell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Immunocell Therapy Sales Forecast by Type (2026-2035) & (K Units)
Table 148. Global Immunocell Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Immunocell Therapy Price Forecast by Type (2026-2035) & (USD/Unit)
Table 150. Global Immunocell Therapy Sales (K Units) Forecast by Application (2026-2035)
Table 151. Global Immunocell Therapy Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Immunocell Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immunocell Therapy Market Size (M USD), 2025-2035
Figure 5. Global Immunocell Therapy Market Size (M USD) (2020-2035)
Figure 6. Global Immunocell Therapy Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Immunocell Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Immunocell Therapy Product Life Cycle
Figure 13. Immunocell Therapy Sales Share by Manufacturers in 2025
Figure 14. Global Immunocell Therapy Revenue Share by Manufacturers in 2025
Figure 15. Immunocell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Immunocell Therapy Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Immunocell Therapy Revenue in 2025
Figure 18. Industry Chain Map of Immunocell Therapy
Figure 19. Global Immunocell Therapy Market PEST Analysis
Figure 20. Global Immunocell Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Immunocell Therapy Market Share by Type
Figure 27. Sales Market Share of Immunocell Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Immunocell Therapy by Type in 2025
Figure 29. Market Share of Immunocell Therapy by Type (2020-2025)
Figure 30. Market Share of Immunocell Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Immunocell Therapy Market Share by Application
Figure 33. Global Immunocell Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Immunocell Therapy Sales Market Share by Application in 2025
Figure 35. Global Immunocell Therapy Market Share by Application (2020-2025)
Figure 36. Global Immunocell Therapy Market Share by Application in 2025
Figure 37. Global Immunocell Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Immunocell Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Immunocell Therapy Market Size by Region (2020-2025)
Figure 40. North America Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Immunocell Therapy Sales Market Share by Country in 2024
Figure 43. North America Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Immunocell Therapy Market Size by Country in 2024
Figure 45. U.S. Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Immunocell Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Immunocell Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Immunocell Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Immunocell Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Immunocell Therapy Sales Market Share by Country in 2024
Figure 53. Europe Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Immunocell Therapy Market Size by Country in 2024
Figure 55. Germany Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Immunocell Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Immunocell Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Immunocell Therapy Market Size by Region in 2024
Figure 68. China Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Immunocell Therapy Sales and Growth Rate (K Units)
Figure 79. South America Immunocell Therapy Sales Market Share by Country in 2024
Figure 80. South America Immunocell Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Immunocell Therapy Market Size by Country in 2024
Figure 82. Brazil Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Immunocell Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Immunocell Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Immunocell Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Immunocell Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Immunocell Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Immunocell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Immunocell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Immunocell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Immunocell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Immunocell Therapy Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Immunocell Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Immunocell Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Immunocell Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global Immunocell Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global Immunocell Therapy Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Immunocell Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immunocell Therapy Market Size (M USD), 2025-2035
Figure 5. Global Immunocell Therapy Market Size (M USD) (2020-2035)
Figure 6. Global Immunocell Therapy Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Immunocell Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Immunocell Therapy Product Life Cycle
Figure 13. Immunocell Therapy Sales Share by Manufacturers in 2025
Figure 14. Global Immunocell Therapy Revenue Share by Manufacturers in 2025
Figure 15. Immunocell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Immunocell Therapy Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Immunocell Therapy Revenue in 2025
Figure 18. Industry Chain Map of Immunocell Therapy
Figure 19. Global Immunocell Therapy Market PEST Analysis
Figure 20. Global Immunocell Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Immunocell Therapy Market Share by Type
Figure 27. Sales Market Share of Immunocell Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Immunocell Therapy by Type in 2025
Figure 29. Market Share of Immunocell Therapy by Type (2020-2025)
Figure 30. Market Share of Immunocell Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Immunocell Therapy Market Share by Application
Figure 33. Global Immunocell Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Immunocell Therapy Sales Market Share by Application in 2025
Figure 35. Global Immunocell Therapy Market Share by Application (2020-2025)
Figure 36. Global Immunocell Therapy Market Share by Application in 2025
Figure 37. Global Immunocell Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Immunocell Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Immunocell Therapy Market Size by Region (2020-2025)
Figure 40. North America Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Immunocell Therapy Sales Market Share by Country in 2024
Figure 43. North America Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Immunocell Therapy Market Size by Country in 2024
Figure 45. U.S. Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Immunocell Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Immunocell Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Immunocell Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Immunocell Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Immunocell Therapy Sales Market Share by Country in 2024
Figure 53. Europe Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Immunocell Therapy Market Size by Country in 2024
Figure 55. Germany Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Immunocell Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Immunocell Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Immunocell Therapy Market Size by Region in 2024
Figure 68. China Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Immunocell Therapy Sales and Growth Rate (K Units)
Figure 79. South America Immunocell Therapy Sales Market Share by Country in 2024
Figure 80. South America Immunocell Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Immunocell Therapy Market Size by Country in 2024
Figure 82. Brazil Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Immunocell Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Immunocell Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Immunocell Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Immunocell Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Immunocell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Immunocell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Immunocell Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Immunocell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Immunocell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Immunocell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Immunocell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Immunocell Therapy Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Immunocell Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Immunocell Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Immunocell Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global Immunocell Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global Immunocell Therapy Market Share Forecast by Application (2026-2035)
